Introduction
============

Epigenetics is the study of heritable changes in gene expression that are not caused by changes to the DNA sequence itself, but by covalent modifications such as DNA methylation (DNA-M) [@B1]. Mammalian DNA-M, which primarily involves the addition of a methyl group to a cytosine base in a CpG dinucleotide, results in increased gene expression when it occurs at higher levels within the gene\'s body instead of its promoter region [@B2]. On a similar note, promoter methylation is of particular epigenetic importance because the vast majority of those located upstream of a gene contain a CpG island, the latter of which is a region with a high concentration of CpG sites [@B3]. In contrast to the hypermethylated CpG sites scattered throughout the human genome, CpG islands are not methylated, and the methylation of CpG islands initiates remodeling mechanisms that ultimately result in gene silencing [@B4], [@B5].

The methylation status of promoters is integral to maintaining normal expression levels of the genes they regulate. In fact, promoter hypermethylation is a key part of cancer development and progression, as it results in the silencing of tumor suppressor gene expression [@B6]. In addition, host promoter hypermethylation has also been implicated in infections by both oncogenic and non-oncogenic viruses such as the human papillomaviruses (HPV) [@B7]. HPV comprises a family of double-stranded DNA viruses that exclusively infect the basal epithelium of the skin and mucosa [@B8]. The majority of HPV infections are asymptomatic and resolve without the need for medical intervention but, depending on the individual and the HPV type, can also result in a number of malignancies and dermatological diseases [@B9]. One such condition is the wart, which arises due to the benign proliferation of HPV-infected epithelial keratinocytes [@B10]. The most prevalent type of wart is the common wart, which accounts for nearly 70% of all cutaneous warts encountered in clinical settings [@B11]. As a result of their benign nature, common warts are subject to a much lesser degree of scrutiny than other HPV-associated diseases.

The impermanent nature of cutaneous warts strongly suggests that epigenetic changes are involved in the mechanism of wart formation and their eventual disappearance. However, a paucity of information exists regarding the methylation status of cutaneous warts, especially in the context of the promotor regions. Therefore, the primary objective of the current study was to provide an exploratory survey of the genome-wide changes in promoter methylation patterns in cutaneous warts compared to healthy skin.

Materials and Methods
=====================

Study participants
------------------

Ethical approval to conduct this study was obtained from Jordan University of Science and Technology\'s (JUST) Institutional Review Board (IRB). Twelve Arab males presenting with common warts were recruited from the general population after providing written informed consent. Shave biopsies of common warts and adjacent normal skin were performed, allowing paired tissue samples (wart and normal skin) to be obtained from each participant.

Whole genome bisulfite sequencing
---------------------------------

A QIAamp DNA Mini Kit (Qiagen, Germany) was used to perform DNA extraction, and optional RNase A digestion was incorporated. DNA purity and integrity were determined by means of the BioTek PowerWave XS2 Spectrophotometer (BioTek Instruments, Inc., USA) and agarose gel electrophoresis, respectively. Genomic DNA that fulfilled our standards for quality and quantity were shipped on dry ice to the Australian Genome Research Facility (AGRF) in Melbourne, where the quality was further ascertained by the QuantiFluor® dsDNA System (Promega, USA). The Zymo EZ DNA Methylation Kit (Zymo Research, USA) was utilized in order to perform bisulfite conversion on the 24 samples. Lastly, the samples were inputted into the Infinium MethylationEPIC BeadChip microarray (Illumina, USA) for a genome-wide interrogation of over 850,000 CpG sites.

Data processing
---------------

RnBeads, a computational R package, was adapted to process and analyze the raw intensity data (IDAT files) from the BeadChip [@B12]. Quality control, preprocessing, batch effects adjustment, and normalization were carried out on all probes and samples according to the RnBeads package pipeline.

Differential methylation and statistical analysis
-------------------------------------------------

The mean of the mean β (mean.mean β) values of all the interrogated CpG sites in each promoter were computed. The distribution of CpG sites per promoter is shown in **Figure [1](#F1){ref-type="fig"}**, while **Figure [2](#F2){ref-type="fig"}** depicts the distribution of CpG sites across promoters. DM for each promoter was calculated using the following three measures: the mean.mean β difference between warts (W) and normal skin (NS), the log~2~ of the mean quotient in β means across all CpG sites in a promoter, and the adjusted combined p-value of all CpG sites in the promoter using a limma statistical test [@B12], [@B13]. Furthermore, these three measures were used to create a combined ranking, in which promoters that exhibit more DM are assigned a lower combined rank [@B12]. Promoters were sorted from smallest to largest using the combined rank score, and the top-ranking 1000 DM promoters were selected for further analysis. In order to correct for multiple testing, the Benjamini-Hochberg procedure was utilized to set the false discovery rate (FDR) at 5%.

Gene ontology enrichment analysis
---------------------------------

Enrichment analysis for gene ontology (GO) terms associated with the top-ranking 500 DM promoters was performed using the GO consortium [@B14].

Signaling pathway analysis
--------------------------

A signaling network of the top-ranking 1000 DM promoters was investigated using the SIGnaling Network Open Resource (SIGNOR) 2.0 [@B15]. Due to the large number of connections, the type of relation was selected to only include \'direct\' interactions with a relaxed layout and a score of \'0.0\'.

Results
=======

Sample clustering based on methylation data
-------------------------------------------

Based on all methylation values of the top-ranking 1000 DM promoters, the 24 samples showed an expected clustering pattern, as samples with similar methylation patterns or phenotypes tended to cluster together (**Figure [3](#F3){ref-type="fig"}**). In addition, the dimension reduction test was applied to the dataset using multidimensional scaling (MDS) and principal component analysis (PCA) in order to inspect for a strong signal in the methylation values of the samples (**Figures [4](#F4){ref-type="fig"}** and**5**). MDS and PCA confirmed that the difference between wart (W) and normal skin (NS) samples predominated the analysis.

Differential methylation of promoters
-------------------------------------

44,929 genomic identifiers passed the quality control and pre-processing steps, including some identifiers that did not map to gene symbols or which were not assigned (NA). Genomic identifiers without symbols were then removed, leaving 27,790 with symbols. The list of DM promoters in warts was limited to the top-ranking 1000 DM promoters using the combined rank score. Using this scoring method, a total of 576 and 424 promoters were found to be hypomethylated and hypermethylated, respectively, in warts (W) compared to normal skin (NS), with a mean β difference =\>0.064 and =\< -0.064 and p-value =\< 0.001 (adjusted p-value =\<0.007) (**Figure [6](#F6){ref-type="fig"}**). Among the 576 hypomethylated promoters, the β difference ranged from -0.064 to -0.458, while the mean β difference ranged between 0.064 and 0.367 for the 424 hypermethylated promoters. The log~2~ of the quotient in methylation between warts and normal skin had a maximum value of 1.633 and minimum value of -1.924 (**Figure [7](#F7){ref-type="fig"}**). The top-ranking 100 DM promoters with the lowest combined rank score are shown in **Table [1](#T1){ref-type="table"}**.

Gene ontology enrichment analysis
---------------------------------

Gene ontology (GO) enrichment analysis of biological process (BP) and molecular function (MF) was conducted on the top-ranking 500 DM hypermethylated promoters (**Figure [8](#F8){ref-type="fig"}**, **Figure [9](#F9){ref-type="fig"}**, **Table [2](#T2){ref-type="table"}**, and **Table [3](#T3){ref-type="table"}**) and the top-ranking 500 DM hypomethylated promoters (**Figure [10](#F10){ref-type="fig"}**, **Figure [11](#F11){ref-type="fig"}**, **Table [4](#T4){ref-type="table"}**, and **Table [5](#T5){ref-type="table"}**).

Pathway analysis
----------------

Signaling network analysis of the top-ranking 1000 DM promoters illustrated that several promoter genes were common regulators of this gene network, with a minimum of 7 direct connectivities each. These promoter genes include *H3F3A*, *CDKN1A*, *MAPK13*, *IKBKG*, *CAPN2*, *CAMKK1* and *CUL1* (**Figure [12](#F12){ref-type="fig"}**). Moreover, *H3F3A* was found to be the most common regulator when the signaling network analysis was carried out on the top 100 DM promoters.

Discussion
==========

To the best of the authors\' knowledge, this is the first study to investigate the genome-wide changes in promoter methylation patterns associated with HPV-induced cutaneous warts. The present findings provide an exploratory analysis that creates clear lines of future research on this topic, especially with regard to validation studies involving larger sample sizes.

In the present study, the most differentially methylated (DM) promoter in warts compared to normal skin was found within the eukaryotic translation initiation factor 3 subunit E pseudogene 2 (*EIF3EP2*) gene, a pseudogene with no function or association previously reported in the literature. Likewise, little is known about the second most DM gene in warts, the chromosome 9 open reading frame 30 (*C9orf30*) pseudogene. In contrast, the third most DM gene is the protein-coding cysteinyl leukotriene receptor 1 (*CYSLTR1*) gene, which is normally involved in allergic and hypersensitive reactions [@B16]. Variation in the *CYSLTR1* gene modulates asthma risk as well as adenoid hypertrophy progression, and it has been implicated in the disease outcome of colorectal, prostate, and squamous cell carcinoma [@B17]-[@B21]. Moreover, *CYSLTR1* is highly expressed in the normal human skin epidermis, but its expression was found to be even higher in atopic dermatitis [@B22]. **Table [2](#T2){ref-type="table"}** depicts all the protein-coding genes containing DM promoters from among the top-ranking 100 listed in **Table [1](#T1){ref-type="table"}**.

Among the protein-coding genes*, C10orf99* and *KRT6B* promoters exhibited high levels of differential methylation in warts. The chromosome 10 open reading frame 99 (*C10orf99*) gene encodes for an antimicrobial peptide that is widely expressed in the skin and digestive tract [@B23]. In a pathologic context, *C10orf99* was determined to contribute to psoriasis development by promoting keratinocyte proliferation [@B24], [@B25]. Likewise, the keratin 6B (*KRT6B*) gene encodes for a type II keratin that is normally present in mammalian epithelial cells and is rapidly induced in human keratinocytes after skin wounding [@B26]. *KRT6B* has been identified as a potential biomarker for differentiating between lung adenocarcinoma and lung squamous cell carcinoma, and its increased expression is associated with lower disease-free survival rates in young breast cancer patients [@B27], [@B28]. Mutations in the *KRT6B* gene result in an autosomal dominant skin disorder known as pachyonychia congenita, which involves plantar keratoderma and pain alongside thickened toenails [@B29]. In contrast, two of the most differentially methylated protein-coding promoters, namely the kallikrein related peptidase 2 (*KLK2*) and Izumo sperm-egg fusion 1 (*IZUMO1*) genes, are integral for sperm function. *KLK2* over-expression has been associated with the promotion of prostate cancer cell growth [@B30].

As previously mentioned, the ephemeral nature of warts hints towards the involvement of an epigenetic component. Correspondingly, some of the most DM promoters were found within the laminin subunit alpha 4 (*LAMA4*) and H3 histone family member 3B (*H3F3B*) genes, which are responsible for cell differentiation and nucleosomal displacement, respectively [@B31], [@B32]. In certain breast cancer subtypes, increased *LAMA4* expression was noted to contribute to the chromatin remodeling mechanisms that are a part of cancer progression [@B33]. Moreover, atypical *HF3B* expression was reported to be associated with colorectal cancer and chondroblastoma [@B34], [@B35]. On a similar note, epigenetic modifications have been linked to changes in metabolism in a number of different non-communicable diseases, including cancer and diabetes [@B36]. In the present study, promoters were differentially methylated within the 17β-hydroxysteroid dehydrogenase type 14 (*HSD17B14*), leukotriene C4 synthase (*LTC4S*), folate receptor 3 (*FOLR3*), alcohol dehydrogenase 7 (*ADH7*), and adiponectin receptor 2 (*ADIPOR2*) genes that are involved in steroid, eicosanoid, folate, retinol, and glucose and lipid metabolism, respectively [@B37]-[@B41]. Like the *CYSLTR1* gene, *LTC4S* polymorphisms were associated with asthma risk and drug responsiveness in different ethnic populations [@B42]-[@B45].

Pathway analysis demonstrated that the most common regulator among the top-ranking 1000 DM promoters was the H3 histone family member 3A (*H3F3A*) gene. Like the *H3F3B* gene, *H3F3A* encodes for a histone variant and is involved in transcriptional regulation [@B46]. Aberrant *H3F3A* expression has been associated with the promotion of pediatric and adolescent cancers as well as lung cancer cell migration [@B46], [@B47]. The second most common regulator was the cyclin dependent kinase inhibitor 1A (*CDKN1A*) gene, which is mostly involved in CDK2 inhibition and is a primary target of p53 activity [@B48]. The *CDKN1A* gene was associated with better patient survival in HPV-related oropharyngeal squamous cell carcinoma [@B49]. The third most common regulator in HPV-induced warts is the mitogen-activated protein kinase 13 (*MAPK13*) gene. *MAPK13* is a member of the MAP kinase family and functions to regulate cellular responses to a range of different stimuli, especially in the context of keratinocyte apoptosis and skin homeostasis [@B50]. Analysis of genome-wide promoter methylation revealed that *MAPK13* was hypermethylated in the majority of primary and metastatic melanomas [@B51]. *MAPK13* was also found to be hypermethylated in esophageal squamous cell carcinoma [@B52].

In summary, it is apparent that HPV-induced warts possess certain patterns of promoter methylation that could be responsible for their formation and maintenance. One limitation of the current study is that it is not possible at this stage to determine whether the differential methylation occurred as a result of the host cells\' response to infection or due to HPV-driven processes responsible for wart formation and progression. Future research is required in order to assess the functional and clinical importance of the hypo- and hypermethylated promoter sites as well as to determine the exact nature of this differential methylation.
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![Heatmap showing the hierarchical clustering of samples displaying only the top-ranking 1000 most variable promoters with the highest variance across all samples. Clustering utilized complete linkage and Manhattan distance. The top x-axis shows the normal skin (NS) and wart (W) samples, while the bottom x-axis shows the patient identification number. Values of 0 (red color) and 1 (purple color) indicate decreased and increased methylation, respectively.](ijmsv17p0191g003){#F3}

![Two-dimensional scatterplot illustrating sample positions after the application of Kruskal\'s non-metric multidimensional scaling based on the matrix of average methylation and Manhattan distance.](ijmsv17p0191g004){#F4}

![Two-dimensional scatterplot showing sample positions after principal component analysis.](ijmsv17p0191g005){#F5}

![Two-dimensional scatterplot of the top-ranking 1000 DM promoters. The mean.mean β values of normal skin (NS) and warts (W) are shown on the x-axis and y-axis, respectively. The methylation β values range from 0 (unmethylated) to 1 (methylated).](ijmsv17p0191g006){#F6}

![Volcano plot of the promoter differential methylation quantified by the log~2~ of the quotient in mean.mean methylation and adjusted combined p-value between warts (W) and normal skin (NS). The color scale represents the combined ranking.](ijmsv17p0191g007){#F7}

![Word cloud illustrating the significant biological processes (BP) associated with the top-ranking 500 hypermethylated promoters.](ijmsv17p0191g008){#F8}

![Word cloud illustrating the significant molecular functions (MF) associated with the top-ranking 500 hypermethylated promoters.](ijmsv17p0191g009){#F9}
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![Word cloud illustrating the significant molecular functions (MF) associated with the top-ranking 500 hypomethylated promoters.](ijmsv17p0191g011){#F11}

![Pathway signaling network generated from the top-ranking 1000 DM promoters.](ijmsv17p0191g012){#F12}

![Pathway signaling network generated from the top-ranking 100 DM promoters.](ijmsv17p0191g013){#F13}

###### 

The 100 top-ranking promoters based on combined ranking score.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene                               Gene symbol            Category         RNA class   Chromosome   mean.mean β value (NS)   mean.mean β value (W)   mean.mean β value diff.\   mean.mean. quot.log~2~   comb.p.val   comb.p.adj. (FDR)   Combined rank
                                                                                                                                                       (W-NS)                                                                               
  ---------------------------------- ---------------------- ---------------- ----------- ------------ ------------------------ ----------------------- -------------------------- ------------------------ ------------ ------------------- ---------------
  ENSG00000224674                    EIF3EP2                Pseudogene                   2            0.611                    0.154                   -0.458                     -1.924                   7.832E-16    3.519E-11           1

  ENSG00000263368                    AC069366.1             Pseudogene       antisense   17           0.206                    0.573                   0.367                      1.431                    1.336E-13    2.001E-09           14

  ENSG00000173198                    CYSLTR1                Protein coding               X            0.166                    0.520                   0.353                      1.580                    1.671E-11    4.415E-08           17

  ENSG00000266228                    MIR3611                RNA gene         miRNA       10           0.403                    0.128                   -0.275                     -1.584                   1.083E-11    3.744E-08           27

  ENSG00000267125                    AC012615.3             RNA gene                     19           0.192                    0.465                   0.273                      1.280                    3.531E-13    3.410E-09           29

  ENSG00000270808                    AC022400.4             Pseudogene       lncRNA      10           0.691                    0.295                   -0.396                     -1.202                   1.686E-10    1.756E-07           40

  ENSG00000241114                    AC008280.2             Pseudogene                   2            0.383                    0.129                   -0.254                     -1.503                   1.876E-10    1.756E-07           47

  ENSG00000272156                    AC008280.3             RNA gene                     2            0.383                    0.129                   -0.254                     -1.503                   1.876E-10    1.756E-07           47

  ENSG00000207258                    RF00019                RNA gene         Y RNA       1            0.508                    0.192                   -0.315                     -1.356                   6.373E-10    4.522E-07           62

  ENSG00000226545                    AL357552.1             Pseudogene                   1            0.508                    0.192                   -0.315                     -1.356                   6.373E-10    4.522E-07           62

  ENSG00000270002                    AC022028.2             RNA gene                     10           0.458                    0.199                   -0.259                     -1.056                   5.656E-10    4.246E-07           70

  ENSG00000227096                    HMGB3P8                Pseudogene                   10           0.653                    0.246                   -0.408                     -1.376                   1.138E-09    6.141E-07           82

  ENSG00000250532                    AC021180.1             RNA gene                     4            0.621                    0.233                   -0.388                     -1.378                   1.576E-09    7.956E-07           89

  ENSG00000254653                    AC024475.1             RNA gene                     11           0.228                    0.440                   0.212                      1.071                    1.411E-10    1.756E-07           99

  ENSG00000265503                    MIR1269B               RNA gene         miRNA       17           0.346                    0.141                   -0.205                     -1.239                   1.140E-09    6.141E-07           109

  ENSG00000238024                    DDX39BP2               Pseudogene                   6            0.326                    0.124                   -0.202                     -1.323                   1.391E-09    7.248E-07           113

  ENSG00000273044                    AL022334.2             RNA gene                     22           0.243                    0.481                   0.238                      0.956                    1.766E-10    1.756E-07           119

  ENSG00000234105                    AC009468.2             RNA gene                     7            0.576                    0.307                   -0.269                     -0.961                   3.100E-09    1.151E-06           121

  ENSG00000188373                    C10orf99               Protein coding               10           0.400                    0.202                   -0.198                     -0.982                   5.786E-10    4.262E-07           124

  ENSG00000271597                    AC112230.1             Pseudogene       lncRNA      2            0.306                    0.594                   0.287                      0.933                    3.019E-09    1.151E-06           136

  ENSG00000271265                    AL355297.3             RNA gene         lncRNA      6            0.347                    0.667                   0.320                      0.924                    1.317E-11    3.856E-08           145

  ENSG00000244286                    ITGB5-AS1              RNA gene         ncRNA       3            0.202                    0.393                   0.190                      1.223                    8.912E-12    3.640E-08           152

  ENSG00000226403                    AL392089.1             RNA gene                     9            0.080                    0.269                   0.189                      1.633                    1.086E-12    6.969E-09           154

  ENSG00000234936                    AC010883.1             RNA gene                     2            0.288                    0.498                   0.210                      0.909                    2.020E-11    4.908E-08           158

  ENSG00000203527                    Z99756.1               RNA gene         ncRNA       22           0.385                    0.198                   -0.187                     -0.906                   5.290E-09    1.674E-06           161

  ENSG00000242147                    AL365356.5             RNA gene         ncRNA       10           0.334                    0.148                   -0.186                     -1.263                   3.506E-11    7.161E-08           166

  ENSG00000270781                    AC091133.5             Pseudogene                   17           0.416                    0.219                   -0.197                     -0.896                   4.980E-10    3.925E-07           170

  ENSG00000250282                    AC002401.2             RNA gene                     17           0.225                    0.443                   0.217                      0.894                    3.488E-09    1.234E-06           174

  ENSG00000255158                    AC131934.1             RNA gene                     11           0.299                    0.590                   0.291                      0.977                    1.016E-08    2.625E-06           174

  ENSG00000232486                    AL592437.2             Pseudogene                   9            0.666                    0.354                   -0.312                     -0.892                   1.930E-09    8.758E-07           175

  ENSG00000262067                    AC120057.1             Pseudogene       lncRNA      17           0.505                    0.171                   -0.333                     -1.505                   1.139E-08    2.816E-06           181

  ENSG00000266258                    LINC01909              RNA gene         ncRNA       18           0.629                    0.299                   -0.330                     -1.048                   1.479E-08    3.408E-06           195

  ENSG00000257496                    AC025031.1             RNA gene                     12           0.217                    0.397                   0.180                      0.982                    1.649E-08    3.703E-06           200

  ENSG00000185479                    KRT6B                  Protein-coding               12           0.340                    0.166                   -0.174                     -1.045                   7.004E-11    1.124E-07           216

  ENSG00000270255                    AC009884.2             Pseudogene                   8            0.279                    0.529                   0.250                      0.900                    2.221E-08    4.587E-06           217

  ENSG00000167751                    KLK2                   Protein coding               19           0.328                    0.136                   -0.192                     -1.214                   2.772E-08    5.463E-06           227

  ENSG00000268518                    AC020909.2             RNA gene                     19           0.432                    0.238                   -0.194                     -0.839                   2.897E-11    6.197E-08           229

  ENSG00000243795                    LINC02044              RNA gene         ncRNA       3            0.387                    0.663                   0.276                      0.825                    1.229E-11    3.856E-08           246

  ENSG00000267632                    AC067852.3             RNA gene         lncRNA      17           0.402                    0.719                   0.316                      0.821                    1.561E-10    1.756E-07           254

  ENSG00000259265                    AC027088.3             RNA gene                     15           0.362                    0.195                   -0.167                     -0.918                   2.209E-08    4.587E-06           260

  ENSG00000264733                    MIR4718                RNA gene         miRNA       16           0.342                    0.176                   -0.166                     -0.922                   1.674E-09    8.164E-07           263

  ENSG00000253630                    AC026407.1             Pseudogene       antisense   5            0.537                    0.301                   -0.236                     -0.815                   1.148E-09    6.141E-07           264

  ENSG00000228918                    LINC01344              RNA gene         ncRNA       1            0.180                    0.346                   0.166                      0.908                    4.232E-10    3.475E-07           264

  ENSG00000232878                    DPYD-AS1               RNA gene         ncRNA       1            0.572                    0.387                   -0.185                     -0.815                   4.216E-08    7.523E-06           265

  ENSG00000112769                    LAMA4                  Protein coding               6            0.325                    0.512                   0.187                      0.810                    3.888E-08    7.072E-06           269

  ENSG00000237126                    AC073254.1             RNA gene                     2            0.368                    0.202                   -0.166                     -0.835                   1.684E-08    3.745E-06           270

  ENSG00000256746                    AC018410.1             RNA gene         ncRNA       11           0.344                    0.536                   0.192                      0.807                    2.084E-09    9.002E-07           271

  ENSG00000232560                    C21orf37               RNA gene         ncRNA       21           0.300                    0.495                   0.195                      0.805                    5.048E-08    8.338E-06           274

  ENSG00000198796                    ALPK2                  Protein coding               18           0.165                    0.329                   0.163                      0.924                    1.006E-08    2.622E-06           286

  ENSG00000185432                    METTL7A                Protein coding               12           0.389                    0.673                   0.283                      0.795                    7.318E-13    5.480E-09           286

  ENSG00000087076                    HSD17B14               Protein coding               19           0.145                    0.346                   0.201                      1.168                    5.925E-08    9.251E-06           287

  ENSG00000239255                    AC007620.1             Pseudogene                   3            0.347                    0.575                   0.227                      1.085                    6.353E-08    9.775E-06           292

  ENSG00000230403                    LINC01066              RNA gene         ncRNA       13           0.475                    0.302                   -0.173                     -0.902                   8.129E-08    1.192E-05           306

  ENSG00000132475                    H3F3B                  Protein coding               17           0.173                    0.358                   0.184                      1.003                    8.349E-08    1.218E-05           308

  ENSG00000258274                    AC012085.2             RNA gene         ncRNA       12           0.415                    0.624                   0.208                      0.785                    6.143E-11    1.062E-07           308

  ENSG00000244167                    AC005532.2             Pseudogene       lncRNA      7            0.488                    0.281                   -0.207                     -0.775                   4.380E-08    7.657E-06           324

  ENSG00000266740                    MIR4708                RNA gene         miRNA       14           0.240                    0.416                   0.177                      0.771                    4.844E-10    3.887E-07           328

  ENSG00000258657                    AL136018.1             RNA gene                     14           0.448                    0.234                   -0.213                     -0.946                   1.163E-07    1.588E-05           329

  ENSG00000186715                    MST1L                  Protein coding               1            0.300                    0.145                   -0.156                     -1.006                   6.774E-11    1.124E-07           335

  ENSG00000253543                    AC083923.1             Pseudogene                   8            0.277                    0.121                   -0.156                     -1.127                   6.441E-10    4.522E-07           339

  ENSG00000261095                    AC136285.1             RNA gene         ncRNA       16           0.487                    0.272                   -0.215                     -0.958                   1.368E-07    1.803E-05           341

  ENSG00000213316                    LTC4S                  Protein coding               5            0.211                    0.365                   0.154                      1.075                    1.025E-08    2.631E-06           348

  ENSG00000267299                    AC011444.3             RNA gene                     19           0.141                    0.300                   0.159                      0.752                    2.936E-08    5.687E-06           352

  ENSG00000234502                    FYTTD1P1               Pseudogene                   9            0.361                    0.180                   -0.182                     -0.969                   1.678E-07    2.118E-05           356

  ENSG00000265666                    RARA-AS1               RNA gene         ncRNA       17           0.189                    0.339                   0.151                      0.868                    1.088E-07    1.501E-05           370

  ENSG00000182264                    IZUMO1                 Protein coding               19           0.308                    0.468                   0.160                      0.737                    3.157E-08    5.910E-06           376

  ENSG00000254113                    AC090193.2             RNA gene                     8            0.243                    0.419                   0.177                      0.736                    1.371E-08    3.276E-06           378

  ENSG00000204933                    CD177P1                Pseudogene                   19           0.375                    0.607                   0.232                      0.733                    2.798E-09    1.103E-06           382

  ENSG00000110203                    FOLR3                  Protein coding               11           0.536                    0.357                   -0.180                     -0.746                   1.990E-07    2.311E-05           387

  ENSG00000266964                    FXYD1                  Protein coding               19           0.299                    0.452                   0.154                      0.731                    3.068E-09    1.151E-06           391

  ENSG00000221857                    AC020907.2             RNA gene                     19           0.299                    0.452                   0.154                      0.731                    3.068E-09    1.151E-06           391

  ENSG00000213417                    KRTAP2-4               Protein coding               17           0.471                    0.309                   -0.163                     -0.855                   2.328E-07    2.604E-05           401

  ENSG00000254853                    AP004247.1             Pseudogene                   11           0.247                    0.100                   -0.147                     -1.221                   3.631E-09    1.265E-06           410

  ENSG00000283664; ENSG00000265375   MIR4679-1; MIR4679-2   RNA gene         miRNA       10           0.353                    0.589                   0.236                      0.722                    1.858E-10    1.756E-07           410

  ENSG00000261257                    AP000821.1             RNA gene         lncRNA      11           0.394                    0.543                   0.149                      0.746                    2.524E-07    2.757E-05           411

  ENSG00000204880                    KRTAP4-8               Protein coding               17           0.356                    0.198                   -0.158                     -0.823                   2.945E-07    3.114E-05           425

  ENSG00000215930                    MIR942                 RNA gene         miRNA       1            0.410                    0.266                   -0.144                     -0.782                   8.361E-09    2.305E-06           427

  ENSG00000271680                    AC098935.2             Pseudogene       antisense   1            0.244                    0.100                   -0.144                     -1.211                   4.741E-08    7.978E-06           428

  ENSG00000258380                    AL356805.1             RNA gene                     14           0.292                    0.435                   0.144                      1.043                    2.010E-08    4.354E-06           432

  ENSG00000249717                    AC110760.2             RNA gene         ncRNA       4            0.480                    0.694                   0.213                      0.707                    5.817E-08    9.171E-06           436

  ENSG00000265462; ENSG00000266758   MIR3680-1; MIR3680-2   RNA gene         miRNA       16           0.383                    0.630                   0.247                      0.705                    8.156E-10    5.161E-07           438

  ENSG00000263361                    MIR378H                RNA gene         miRNA       5            0.411                    0.268                   -0.143                     -0.731                   7.162E-08    1.080E-05           443

  ENSG00000249483                    AC026726.1             RNA gene         lncRNA      5            0.114                    0.257                   0.142                      0.852                    1.524E-08    3.459E-06           446

  ENSG00000227735                    CYCSP5                 Pseudogene       antisense   1            0.212                    0.070                   -0.142                     -1.478                   2.842E-09    1.110E-06           449

  ENSG00000267130                    AC008738.2             RNA gene                     19           0.163                    0.310                   0.146                      0.698                    3.087E-08    5.835E-06           449

  ENSG00000269480                    AC020913.2             RNA gene                     19           0.388                    0.226                   -0.162                     -0.755                   4.211E-07    3.933E-05           481

  ENSG00000260673                    AL034376.1             RNA gene                     6            0.392                    0.254                   -0.139                     -0.703                   8.046E-08    1.187E-05           482

  ENSG00000261392                    AC087190.2             RNA gene                     16           0.735                    0.481                   -0.255                     -0.681                   2.657E-07    2.869E-05           488

  ENSG00000196344                    ADH7                   Protein coding               4            0.290                    0.152                   -0.138                     -0.936                   2.488E-07    2.740E-05           488

  ENSG00000170454                    KRT75                  Protein coding               12           0.467                    0.293                   -0.175                     -0.729                   4.448E-07    4.087E-05           489

  ENSG00000254175                    IGLVI-42               Pseudogene                   22           0.232                    0.095                   -0.137                     -1.201                   1.475E-10    1.756E-07           498

  ENSG00000254073                    IGLVVII-41-1           Pseudogene                   22           0.232                    0.095                   -0.137                     -1.201                   1.475E-10    1.756E-07           498

  ENSG00000253947                    AC008705.1             RNA gene                     5            0.393                    0.582                   0.189                      0.677                    1.507E-08    3.438E-06           498

  ENSG00000275874                    PICSAR                 RNA gene         ncRNA       21           0.467                    0.318                   -0.150                     -0.675                   2.541E-07    2.757E-05           503

  ENSG00000233930                    KRTAP5-AS1             RNA gene         ncRNA       11           0.162                    0.298                   0.136                      0.944                    1.138E-08    2.816E-06           503

  ENSG00000188100                    FAM25A                 Protein coding               10           0.389                    0.254                   -0.135                     -0.688                   1.426E-07    1.862E-05           509

  ENSG00000261078                    AC009118.1             RNA gene                     16           0.250                    0.115                   -0.135                     -1.008                   2.220E-08    4.587E-06           513

  ENSG00000259195                    AC021739.1             Pseudogene                   15           0.284                    0.149                   -0.134                     -0.927                   4.219E-08    7.523E-06           519

  ENSG00000260905                    AC009021.1             RNA gene                     16           0.616                    0.384                   -0.232                     -0.667                   8.523E-08    1.235E-05           523

  ENSG00000006831                    ADIPOR2                Protein coding               12           0.721                    0.501                   -0.220                     -0.667                   1.007E-07    1.410E-05           527
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Function and clinical relevance of the protein-coding genes containing the most differentially methylated promoters in warts

  Gene symbol   Gene name                                          Main physiological function
  ------------- -------------------------------------------------- ---------------------------------------------------------------
  *CYSLTR1*     Cysteinyl leukotriene receptor 1                   Mediates bronchoconstriction
  *C10orf99*    Chromosome 10 Open Reading Frame 99                Mediates recruitment of lymphocytes to epithelia
  *KRT6B*       Keratin 6B                                         Epithelial wound repair and inflammation
  *KLK2*        Kallikrein Related Peptidase 2                     Sperm liquefication
  *LAMA4*       Laminin Subunit Alpha 4                            Cell adhesion, differentiation, and migration
  *ALPK2*       Alpha Kinase 2                                     Unknown
  *METTL7A*     Methyltransferase Like 7A                          Unknown
  *HSD17B14*    17β-Hydroxysteroid dehydrogenase type 14           Steroid metabolism
  *H3F3B*       H3 Histone Family Member 3B                        Found at sites of nucleosomal displacement
  *MST1L*       Macrophage Stimulating 1 Like                      Unknown
  *LTC4S*       Leukotriene C4 Synthase                            Involved in cysteinyl leukotriene biosynthesis
  *IZUMO1*      Izumo sperm-egg fusion 1                           Essential for fusion and binding of sperm and egg
  *FOLR3*       Folate receptor 3                                  Mediate delivery of 5-methyltetrahydrofolate to cell interior
  *FXYD1*       FXYD Domain Containing Ion Transport Regulator 1   Regulates ion channel activity
  *KRTAP2-4*    Keratin Associated Protein 2-4                     Involved in hair formation
  *KRTAP4-8*    Keratin Associated Protein 4-8                     Involved in hair formation
  *ADH7*        Alcohol dehydrogenase 7                            Functions in retinoic acid synthesis
  *KRT75*       Keratin 75                                         Involved in hair and nail formation
  *FAM25A*      Family with sequence similarity 25 member A        Unknown
  *ADIPOR2*     Adiponectin receptor 2                             Regulates glucose and lipid metabolism

###### 

GO enrichment analysis showing the significant biological processes (BP) of the top 500 hypermethylated promoters.

  GOMFID       P-value   Odds ratio   ExpCount   Count   Size   Term
  ------------ --------- ------------ ---------- ------- ------ -------------------------------------------------------------------------
  GO:0009913   0         11.3215      2.1081     19      328    epidermal cell differentiation
  GO:0043588   0         9.3276       2.6737     20      409    skin development
  GO:0070268   0         14.8063      0.7126     9       110    cornification
  GO:0031424   0         13.9409      0.664      8       111    keratinization
  GO:0060429   0         3.7163       8.1779     25      1251   epithelium development
  GO:0042742   0         8.0356       1.5624     11      239    defense response to bacterium
  GO:0030154   0         2.5597       26.423     49      4042   cell differentiation
  GO:0006959   0         6.7129       1.4905     9       228    humoral immune response
  GO:0051707   0         3.5529       5.4585     17      835    response to other organism
  GO:0070488   0         Inf          0.0131     2       2      neutrophil aggregation
  GO:0031581   0         58.5596      0.0719     3       11     hemidesmosome assembly
  GO:0009607   1e-04     3.3622       5.7461     17      879    response to biotic stimulus
  GO:0048731   1e-04     2.1729       30.6198    50      4684   system development
  GO:0050832   1e-04     17.986       0.2549     4       39     defense response to fungus
  GO:0032502   2e-04     2.0271       40.0921    59      6133   developmental process
  GO:0016477   2e-04     2.639        9.1062     21      1393   cell migration
  GO:0090630   3e-04     9.5433       0.5753     5       88     activation of GTPase activity
  GO:0061844   5e-04     11.8647      0.3726     4       57     antimicrobial humoral immune response mediated by antimicrobial peptide
  GO:0009605   8e-04     2.5057       8.646      19      1419   response to external stimulus
  GO:0051674   8e-04     2.378        10.0018    21      1530   localization of cell
  GO:0007155   9e-04     2.4699       8.6421     19      1322   cell adhesion
  GO:0031338   0.001     9.819        0.4445     4       68     regulation of vesicle fusion
  GO:0097530   0.001     7.0599       0.7648     5       117    granulocyte migration
  GO:0002376   0.0014    2.0026       18.1078    31      2770   immune system process
  GO:0002523   0.0018    38.6782      0.0654     2       10     leukocyte migration involved in inflammatory response
  GO:0030595   0.0019    4.9654       1.2943     6       198    leukocyte chemotaxis
  GO:0040011   0.002     2.1602       11.4792    22      1756   locomotion
  GO:1904995   0.0022    34.3786      0.0719     2       11     negative regulation of leukocyte adhesion to vascular endothelial cell
  GO:0045104   0.0023    12.6396      0.2615     3       40     intermediate filament cytoskeleton organization
  GO:0030593   0.0025    7.5626       0.5687     4       87     neutrophil chemotaxis
  GO:0003334   0.0027    30.9389      0.0784     2       12     keratinocyte development
  GO:0032119   0.0027    30.9389      0.0784     2       12     sequestering of zinc ion
  GO:0008219   0.0029    2.0056       14.1398    25      2163   cell death
  GO:0030856   0.003     5.4424       0.9806     5       150    regulation of epithelial cell differentiation
  GO:0018119   0.0032    28.1246      0.085      2       13     peptidyl-cysteine S-nitrosylation
  GO:0034497   0.0032    28.1246      0.085      2       13     protein localization to phagophore assembly site
  GO:0032101   0.0034    2.6778       4.8571     12      743    regulation of response to external stimulus
  GO:0022408   0.0036    5.2242       1.0198     5       156    negative regulation of cell-cell adhesion
  GO:0006928   0.0045    1.979        13.0285    23      1993   movement of cell or subcellular component
  GO:0006935   0.0049    2.8124       3.8177     10      584    chemotaxis
  GO:0045087   0.0051    2.4353       5.7853     13      885    innate immune response
  GO:0003336   0.0065    Inf          0.0065     1       1      corneocyte desquamation
  GO:0021593   0.0065    Inf          0.0065     1       1      rhombomere morphogenesis
  GO:0021660   0.0065    Inf          0.0065     1       1      rhombomere 3 formation
  GO:0021666   0.0065    Inf          0.0065     1       1      rhombomere 5 formation
  GO:0033037   0.0065    Inf          0.0065     1       1      polysaccharide localization
  GO:0034516   0.0065    Inf          0.0065     1       1      response to vitamin B6
  GO:0035644   0.0065    Inf          0.0065     1       1      phosphoanandamide dephosphorylation
  GO:0043420   0.0065    Inf          0.0065     1       1      anthranilate metabolic process
  GO:0045660   0.0065    Inf          0.0065     1       1      positive regulation of neutrophil differentiation
  GO:0072046   0.0065    Inf          0.0065     1       1      establishment of planar polarity involved in nephron morphogenesis
  GO:0072740   0.0065    Inf          0.0065     1       1      cellular response to anisomycin
  GO:1905716   0.0065    Inf          0.0065     1       1      negative regulation of cornification
  GO:0006950   0.008     1.6938       24.6188    36      3766   response to stress
  GO:1903036   0.0081    7.7836       0.4118     3       63     positive regulation of response to wounding
  GO:0050729   0.0082    5.354        0.791      4       121    positive regulation of inflammatory response
  GO:0030539   0.0082    16.2749      0.1373     2       21     male genitalia development
  GO:1902807   0.0087    5.2634       0.8041     4       123    negative regulation of cell cycle G1/S phase transition
  GO:0045606   0.0098    14.7231      0.1504     2       23     positive regulation of epidermal cell differentiation
  GO:0001775   0.0099    2.0563       8.459      16      1294   cell activation

###### 

GO enrichment analysis showing the significant molecular functions (MF) of the top 500 hypermethylated promoters.

  GOMFID       P-value   Odds ratio   ExpCount   Count   Size   Term
  ------------ --------- ------------ ---------- ------- ------ --------------------------------------------------------
  GO:0050786   0         99.375       0.0655     4       11     RAGE receptor binding
  GO:0017137   1e-04     7.2337       1.0653     7       179    Rab GTPase binding
  GO:0035662   1e-04     340.8367     0.0179     2       3      Toll-like receptor 4 binding
  GO:0050544   3e-04     113.5986     0.0298     2       5      arachidonic acid binding
  GO:0005200   4e-04     8.9173       0.613      5       103    structural constituent of cytoskeleton
  GO:0045294   0.0019    37.8526      0.0655     2       11     alpha-catenin binding
  GO:0036041   0.0022    34.0653      0.0714     2       12     long-chain fatty acid binding
  GO:0008146   0.0035    10.7307      0.3035     3       51     sulfotransferase activity
  GO:0001856   0.006     Inf          0.006      1       1      complement component C5a binding
  GO:0005130   0.006     Inf          0.006      1       1      granulocyte colony-stimulating factor receptor binding
  GO:0030429   0.006     Inf          0.006      1       1      kynureninase activity
  GO:0036458   0.006     Inf          0.006      1       1      hepatocyte growth factor binding
  GO:0047888   0.006     Inf          0.006      1       1      fatty acid peroxidase activity
  GO:0061981   0.006     Inf          0.006      1       1      3-hydroxykynureninase activity
  GO:1901567   0.0096    14.7995      0.1488     2       25     fatty acid derivative binding

###### 

GO enrichment analysis showing the significant biological processes (BP) of the top 500 hypomethylated promoters.

  GOMFID       P-value   Odds ratio   ExpCount   Count   Size   Term
  ------------ --------- ------------ ---------- ------- ------ ---------------------------------------------------------------------------------------------------------------------
  GO:1901750   0         102.821      0.0789     4       8      leukotriene D4 biosynthetic process
  GO:0006751   0         82.2519      0.0888     4       9      glutathione catabolic process
  GO:0006691   0         21.5282      0.2861     5       29     leukotriene metabolic process
  GO:0046456   1e-04     12.589       0.4538     5       46     icosanoid biosynthetic process
  GO:0051572   3e-04     203.1707     0.0296     2       3      negative regulation of histone H3-K4 methylation
  GO:0006575   4e-04     4.9708       1.7363     8       176    cellular modified amino acid metabolic process
  GO:0072268   6e-04     101.5793     0.0395     2       4      pattern specification involved in metanephros development
  GO:0048762   9e-04     4.3203       1.9829     8       201    mesenchymal cell differentiation
  GO:0072081   9e-04     67.7154      0.0493     2       5      specification of nephron tubule identity
  GO:0022612   0.0012    5.4916       1.1739     6       119    gland morphogenesis
  GO:0040012   0.0012    2.2988       9.4409     20      957    regulation of locomotion
  GO:0030155   0.0015    2.5831       6.2347     15      632    regulation of cell adhesion
  GO:0030334   0.0016    2.3435       8.2867     18      840    regulation of cell migration
  GO:0051893   0.0018    8.3709       0.5229     4       53     regulation of focal adhesion assembly
  GO:0017144   0.0018    2.3773       7.6948     17      780    drug metabolic process
  GO:0048293   0.002     40.6244      0.0691     2       7      regulation of isotype switching to IgE isotypes
  GO:0086036   0.002     40.6244      0.0691     2       7      regulation of cardiac muscle cell membrane potential
  GO:0032412   0.002     3.7493       2.269      8       230    regulation of ion transmembrane transporter activity
  GO:0033598   0.0023    12.7584      0.2664     3       27     mammary gland epithelial cell proliferation
  GO:0071493   0.0026    33.8516      0.0789     2       8      cellular response to UV-B
  GO:1902041   0.0027    7.455        0.582      4       59     regulation of extrinsic apoptotic signaling pathway via death domain receptors
  GO:0035148   0.003     4.523        1.4107     6       143    tube formation
  GO:0016064   0.0031    5.4155       0.9865     5       100    immunoglobulin mediated immune response
  GO:0033689   0.0033    29.0139      0.0888     2       9      negative regulation of osteoblast proliferation
  GO:0045869   0.0033    29.0139      0.0888     2       9      negative regulation of single stranded viral RNA replication via double stranded DNA intermediate
  GO:0070383   0.0033    29.0139      0.0888     2       9      DNA cytosine deamination
  GO:0072048   0.0033    29.0139      0.0888     2       9      renal system pattern specification
  GO:0051270   0.0034    2.1328       9.579      19      971    regulation of cellular component movement
  GO:0043001   0.0035    10.9332      0.3058     3       31     Golgi to plasma membrane protein transport
  GO:0032409   0.0035    3.421        2.4761     8       251    regulation of transporter activity
  GO:0071526   0.0038    10.5555      0.3157     3       32     semaphorin-plexin signaling pathway
  GO:0043648   0.0038    5.1432       1.0358     5       105    dicarboxylic acid metabolic process
  GO:0001756   0.0041    6.6105       0.6511     4       66     somitogenesis
  GO:0009972   0.0041    25.3857      0.0987     2       10     cytidine deamination
  GO:0046087   0.0041    25.3857      0.0987     2       10     cytidine metabolic process
  GO:0035510   0.0041    10.2031      0.3255     3       33     DNA dealkylation
  GO:0048870   0.0043    1.8716       15.0936    26      1530   cell motility
  GO:0070988   0.0048    6.3043       0.6807     4       69     demethylation
  GO:0030307   0.0048    4.0729       1.5587     6       158    positive regulation of cell growth
  GO:0034754   0.0049    4.8503       1.095      5       111    cellular hormone metabolic process
  GO:0060766   0.005     22.5637      0.1085     2       11     negative regulation of androgen receptor signaling pathway
  GO:0007045   0.0056    6.0251       0.7103     4       72     cell-substrate adherens junction assembly
  GO:0060429   0.0058    1.9184       12.3412    22      1251   epithelium development
  GO:0001867   0.006     20.3061      0.1184     2       12     complement activation, lectin pathway
  GO:0016554   0.006     20.3061      0.1184     2       12     cytidine to uridine editing
  GO:0046133   0.006     20.3061      0.1184     2       12     pyrimidine ribonucleoside catabolic process
  GO:0072520   0.006     20.3061      0.1184     2       12     seminiferous tubule development
  GO:0048513   0.0067    1.5794       33.344     47      3380   animal organ development
  GO:0032101   0.0068    2.1741       7.3298     15      743    regulation of response to external stimulus
  GO:0001838   0.007     4.4295       1.1937     5       121    embryonic epithelial tube formation
  GO:0045995   0.007     4.4295       1.1937     5       121    regulation of embryonic development
  GO:0010566   0.007     18.459       0.1282     2       13     regulation of ketone biosynthetic process
  GO:0002699   0.007     3.7491       1.6869     6       171    positive regulation of immune effector process
  GO:0016053   0.0076    2.6059       4.0447     10      410    organic acid biosynthetic process
  GO:0045668   0.0076    8.0512       0.4045     3       41     negative regulation of osteoblast differentiation
  GO:0090382   0.0076    8.0512       0.4045     3       41     phagosome maturation
  GO:0050772   0.0077    5.4604       0.7793     4       79     positive regulation of axonogenesis
  GO:1901888   0.0081    5.3882       0.7892     4       80     regulation of cell junction assembly
  GO:0000722   0.0081    16.9197      0.1381     2       14     telomere maintenance via recombination
  GO:0042446   0.0084    5.3179       0.7991     4       81     hormone biosynthetic process
  GO:0001667   0.0085    2.56         4.1137     10      417    ameboidal-type cell migration
  GO:0030278   0.0092    3.5327       1.7856     6       181    regulation of ossification
  GO:0010959   0.0092    2.6793       3.5317     9       358    regulation of metal ion transport
  GO:1904062   0.0094    2.8684       2.9299     8       297    regulation of cation transmembrane transport
  GO:0000415   0.0099    Inf          0.0099     1       1      negative regulation of histone H3-K36 methylation
  GO:0003147   0.0099    Inf          0.0099     1       1      neural crest cell migration involved in heart formation
  GO:0030209   0.0099    Inf          0.0099     1       1      dermatan sulfate catabolic process
  GO:0035713   0.0099    Inf          0.0099     1       1      response to nitrogen dioxide
  GO:0044345   0.0099    Inf          0.0099     1       1      stromal-epithelial cell signaling involved in prostate gland development
  GO:0046901   0.0099    Inf          0.0099     1       1      tetrahydrofolylpolyglutamate biosynthetic process
  GO:0048694   0.0099    Inf          0.0099     1       1      positive regulation of collateral sprouting of injured axon
  GO:0050928   0.0099    Inf          0.0099     1       1      negative regulation of positive chemotaxis
  GO:0060598   0.0099    Inf          0.0099     1       1      dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis
  GO:0061713   0.0099    Inf          0.0099     1       1      anterior neural tube closure
  GO:0061767   0.0099    Inf          0.0099     1       1      negative regulation of lung blood pressure
  GO:0071250   0.0099    Inf          0.0099     1       1      cellular response to nitrite
  GO:0071954   0.0099    Inf          0.0099     1       1      chemokine (C-C motif) ligand 11 production
  GO:0072168   0.0099    Inf          0.0099     1       1      specification of anterior mesonephric tubule identity
  GO:0072169   0.0099    Inf          0.0099     1       1      specification of posterior mesonephric tubule identity
  GO:0072184   0.0099    Inf          0.0099     1       1      renal vesicle progenitor cell differentiation
  GO:0072259   0.0099    Inf          0.0099     1       1      metanephric interstitial fibroblast development
  GO:0090246   0.0099    Inf          0.0099     1       1      convergent extension involved in somitogenesis
  GO:0098749   0.0099    Inf          0.0099     1       1      cerebellar neuron development
  GO:1900281   0.0099    Inf          0.0099     1       1      positive regulation of CD4-positive, alpha-beta T cell costimulation
  GO:1904328   0.0099    Inf          0.0099     1       1      regulation of myofibroblast contraction
  GO:1904635   0.0099    Inf          0.0099     1       1      positive regulation of glomerular visceral epithelial cell apoptotic process
  GO:1904877   0.0099    Inf          0.0099     1       1      positive regulation of DNA ligase activity
  GO:1905580   0.0099    Inf          0.0099     1       1      positive regulation of ERBB3 signaling pathway
  GO:1905943   0.0099    Inf          0.0099     1       1      negative regulation of formation of growth cone in injured axon
  GO:2000080   0.0099    Inf          0.0099     1       1      negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation
  GO:2000184   0.0099    Inf          0.0099     1       1      positive regulation of progesterone biosynthetic process
  GO:2000572   0.0099    Inf          0.0099     1       1      positive regulation of interleukin-4-dependent isotype switching to IgE isotypes

###### 

GO enrichment analysis showing the significant molecular functions (MF) of the top 500 hypomethylated promoters.

  GOMFID       P-value   Odds ratio   ExpCount   Count   Size   Term
  ------------ --------- ------------ ---------- ------- ------ -----------------------------------------------------------------------------------------------------
  GO:0036374   0         105.3038     0.0575     3       6      glutathione hydrolase activity
  GO:0047844   0.0019    41.8516      0.0671     2       7      deoxycytidine deaminase activity
  GO:0000979   0.0045    9.855        0.3354     3       35     RNA polymerase II core promoter sequence-specific DNA binding
  GO:0004126   0.0057    20.9195      0.115      2       12     cytidine deaminase activity
  GO:0050681   0.0075    8.0828       0.4025     3       42     androgen receptor binding
  GO:0031492   0.0091    7.5041       0.4312     3       45     nucleosomal DNA binding
  GO:0003940   0.0096    Inf          0.0096     1       1      L-iduronidase activity
  GO:0004326   0.0096    Inf          0.0096     1       1      tetrahydrofolylpolyglutamate synthase activity
  GO:0004441   0.0096    Inf          0.0096     1       1      inositol-1,4-bisphosphate 1-phosphatase activity
  GO:0008725   0.0096    Inf          0.0096     1       1      DNA-3-methyladenine glycosylase activity
  GO:0008829   0.0096    Inf          0.0096     1       1      dCTP deaminase activity
  GO:0008841   0.0096    Inf          0.0096     1       1      dihydrofolate synthase activity
  GO:0031962   0.0096    Inf          0.0096     1       1      mineralocorticoid receptor binding
  GO:0034512   0.0096    Inf          0.0096     1       1      box C/D snoRNA binding
  GO:0043916   0.0096    Inf          0.0096     1       1      DNA-7-methylguanine glycosylase activity
  GO:0050649   0.0096    Inf          0.0096     1       1      testosterone 6-beta-hydroxylase activity
  GO:0052821   0.0096    Inf          0.0096     1       1      DNA-7-methyladenine glycosylase activity
  GO:0052822   0.0096    Inf          0.0096     1       1      DNA-3-methylguanine glycosylase activity
  GO:0052829   0.0096    Inf          0.0096     1       1      inositol-1,3,4-trisphosphate 1-phosphatase activity
  GO:0086038   0.0096    Inf          0.0096     1       1      calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential
  GO:0031625   0.0096    2.8578       2.9417     8       307    ubiquitin protein ligase binding
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